These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27775939)

  • 41. Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
    Lv K; Guo HM; Lu YJ; Wu ZX; Zhang K; Han JK
    Nucl Med Commun; 2014 Dec; 35(12):1204-11. PubMed ID: 25222911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Forced diuresis and dual-phase F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers.
    Harkirat S; Anand S; Jacob M
    Indian J Radiol Imaging; 2010 Feb; 20(1):13-9. PubMed ID: 20351986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences.
    Plodeck V; Rahbari NN; Weitz J; Radosa CG; Laniado M; Hoffmann RT; Zöphel K; Beuthien-Baumann B; Kotzerke J; van den Hoff J; Platzek I
    Eur Radiol; 2019 Jan; 29(1):422-428. PubMed ID: 29980927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X; Wu F; Han P
    Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proposal of a new acquisition protocol for bladder cancer visualization with 18F-FDG PET/CT.
    Chondrogiannis S; Marzola MC; Colletti PM; Rubello D
    Clin Nucl Med; 2015 Jan; 40(1):e78-80. PubMed ID: 24566416
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.
    Graafland NM; Leijte JA; Valdés Olmos RA; Hoefnagel CA; Teertstra HJ; Horenblas S
    Eur Urol; 2009 Aug; 56(2):339-45. PubMed ID: 19477581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.
    Sürücü E; Polack BD; Demir Y; Durmuşoğlu M; Ekmekçi S; Sarıoğlu S; Çelik AO; Ada E; İkiz AÖ
    Clin Imaging; 2015; 39(5):781-6. PubMed ID: 25721710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Initial Staging of Locally Advanced Rectal Cancer and Regional Lymph Nodes: Comparison of Diffusion-Weighted MRI With 18F-FDG-PET/CT.
    Cerny M; Dunet V; Prior JO; Hahnloser D; Wagner AD; Meuli RA; Schmidt S
    Clin Nucl Med; 2016 Apr; 41(4):289-95. PubMed ID: 26828149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI.
    Kitajima K; Suenaga Y; Ueno Y; Kanda T; Maeda T; Takahashi S; Ebina Y; Miyahara Y; Yamada H; Sugimura K
    Eur J Radiol; 2013 Oct; 82(10):1672-6. PubMed ID: 23727380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.
    Monteil J; Maubon A; Leobon S; Roux S; Marin B; Renaudie J; Genet D; Fermeaux V; Aubard Y; Tubiana-Mathieu N
    Anticancer Res; 2011 Nov; 31(11):3865-71. PubMed ID: 22110211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of early dynamic and delayed post-diuretic
    Sharma A; Mete UK; Sood A; Kakkar N; Gorla AK; Mittal BR
    Br J Radiol; 2017 Apr; 90(1072):20160787. PubMed ID: 28256904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positron emission tomography with the glucose analog [F]-fluoro-2-deoxy-D-glucose for evaluating pelvic lymph node metastasis in uterine corpus cancer: comparison with CT and MRI findings.
    Inubashiri E; Hata K; Kanenishi K; Shiota A; Ohno M; Yamamoto Y; Nishiyama Y; Ohkawa M; Hata T
    J Obstet Gynaecol Res; 2009 Feb; 35(1):26-34. PubMed ID: 19215544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of 18F-FDG PET/CT with retrograde filling of the urinary bladder in patients with suspected pelvic malignancies.
    Vicente AM; Castrejón AS; Muñoz AP; Woll PP; García AN
    J Nucl Med Technol; 2010 Sep; 38(3):128-37. PubMed ID: 20807854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FDG-PET/MRI for the preoperative diagnosis and staging of peritoneal carcinomatosis: a prospective multireader pilot study.
    Vietti Violi N; Gavane S; Argiriadi P; Law A; Heiba S; Bekhor EY; Babb JS; Ghesani M; Labow DM; Taouli B
    Abdom Radiol (NY); 2023 Dec; 48(12):3634-3642. PubMed ID: 36308554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detectability of residual invasive bladder cancer in delayed
    Higashiyama A; Komori T; Juri H; Inada Y; Azuma H; Narumi Y
    Ann Nucl Med; 2018 Oct; 32(8):561-567. PubMed ID: 30014439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective evaluation of 68Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
    Naswa N; Sharma P; Suman Kc S; Lata S; Kumar R; Malhotra A; Bal C
    Nucl Med Commun; 2012 Jul; 33(7):766-74. PubMed ID: 22531829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lymph node staging of bladder neck carcinoma with positron emission tomography].
    Bachor R; Kotzerke J; Reske SN; Hautmann R
    Urologe A; 1999 Jan; 38(1):46-50. PubMed ID: 10081101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.